Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 13;9(8):e102861.
doi: 10.1371/journal.pone.0102861. eCollection 2014.

Atrial fibrillation as a marker of occult cancer

Affiliations

Atrial fibrillation as a marker of occult cancer

Eva B Ostenfeld et al. PLoS One. .

Abstract

Background: Recent studies suggest that cancer increases risk of atrial fibrillation. Whether atrial fibrillation is a marker for underlying occult cancer is unknown.

Methods: We conducted a cohort study (1980-2011) of all Danish patients with new-onset atrial fibrillation. To examine cancer risk, we computed absolute risk at 3 months and standardized incidence ratios (SIRs) by comparing observed cancer incidence among patients newly diagnosed with atrial fibrillation with that expected based on national cancer incidence during the period.

Results: Median follow-up time was 3.4 years among 269 742 atrial fibrillation patients. Within 3 months of follow-up, 6656 cancers occurred (absolute risk, 2.5%; 95% confidence intervals [CI], 2.4%-2.5%) versus 1302 expected, yielding a SIR of 5.11; 95% CI, 4.99-5.24. Associations were particularly strong for cancers of the lung, kidney, colon, ovary, and for non-Hodgkin's lymphoma. The SIR within 3 months of follow-up was 7.02; 95% CI, 6.76-7.28 for metastatic and 3.53; 95% CI, 3.38-3.68 for localized cancer. Beyond 3 months of follow-up, overall cancer risk was modestly increased (SIR, 1.13; 95% CI, 1.12-1.15).

Conclusion: Patients with new-onset atrial fibrillation had a markedly increased relative risk of a cancer diagnosis within the next three months, however, corresponding absolute risk was small.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for all cancer sites following atrial fibrillation by follow-up period, Denmark, 1980–2011.

References

    1. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, et al. (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: The rotterdam study. Eur Heart J 27: 949–953. - PubMed
    1. Kannel WB, Benjamin EJ (2008) Status of the epidemiology of atrial fibrillation. Med Clin North Am 92: : 17–40, ix. - PMC - PubMed
    1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, et al. (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the american college of cardiology Foundation/American heart association task force on practice guidelines developed in partnership with the european society of cardiology and in collaboration with the european heart rhythm association and the heart rhythm society. J Am Coll Cardiol 57: e101–98. - PubMed
    1. Guzzetti S, Costantino G, Vernocchi A, Sada S, Fundaro C (2008) First diagnosis of colorectal or breast cancer and prevalence of atrial fibrillation. Intern Emerg Med 3: 227–231. - PubMed
    1. Guzzetti S, Costantino G, Sada S, Fundaro C (2002) Colorectal cancer and atrial fibrillation: A case-control study. Am J Med 112: 587–588. - PubMed

Publication types

Substances